Table 3.
Samples |
Staphylococcus aureus
|
Streptococcus mutans
|
Escherichia coli
|
Acinetobacter baumannii
|
||||
---|---|---|---|---|---|---|---|---|
IC50 | MIC | IC50 | MIC | IC50 | MIC | IC50 | MIC | |
B1 | 27.94 | 67.87 | 25.15 | 62.61 | 13.56 | 49.98 | 16.89 | 49.24 |
B2 | 34.29 | 72.39 | 26.98 | 68.23 | 12.89 | 30.34 | 20.39 | 44.12 |
B3 | 54.12 | 98.14 | 48.67 | 95.91 | 23.67 | 55.87 | 43.18 | 85.23 |
Ampicillin | 65.91 | >100 | 26.03 | 62.24 | 1.03 | 2.89 | <100 | <100 |
Rifampicin | >100 | >100 | >100 | >100 | 23.81 | 86.23 | 87.12 | <100 |
Notes: The values are in μg/mL. The lowest concentrations of nanoparticle inhibiting ≥90% and 50% with respect to the growth control without nanoparticles were taken as the MIC and IC50, respectively. The experiments were repeated thrice. B1, B2, and B3, gold–silver bimetallic nanoparticles.
Abbreviations: IC50, half maximal inhibitory concentration; MIC, minimum inhibitory concentration.